9th Annual Biomarkers Congress

View Profile

Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2011 Tuberculosis In Cecil’s Textbook of Medicine
2. 2011 Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study Med. 2011. Mar; 8(3):e1000427/Epub 2011 March 15
3. 2011 Tuberculosis In Sande Textbook of Global HIV Medicine
4. 2010 Immunoregulation in tuberculosis: observations and implications ClinTrans Sci. 3: 23-8
5. 2009 Compartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosis. Tuberculosis (Edinb). ;89(1):38-47.
6. 2009 The Emergence of Extensively Drug Resistant Tuberculosis – A Global Health Crisis Requiring New Interventions. Part II. Scientific Advances that May Provide Solutions. Clinical and Translational Science. Volume 2, Issue 1, Date: February 2009, Pages: 80-84.
7. 2009 Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes. Respir Res. ;11:2
8. 2008 Extracellular-regulated kinase activation regulates replication of Mycobacterium avium intracellularly in primary human monocytes. Cell Tissue Res. 332(2):237-44
9. 2008 The Emergence of Extensively Drug Resistant Tuberculosis – A Global Health Crisis Requiring New Interventions. Part I. The Origins of the Problem. Clinical and Translational Sciences. 1(3) : 249-53
10. 2008 Drug resistant TB and HIV in resource-limited settings: what TB/HIV programs can learn from each other? Trop Med Int Health.13(9):1204-7
11. 2008 Rate and amplification of drug resistance in previously treated patients with tuberculosis in Kampala, Uganda Clin Infect Dis. ; 47: 1126-34
12. 2008 Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA J Immunol. 180(3):1826-33
13. 2007 Human immune response in tuberculosis. In Clinical Tuberculosis.
14. 2007 Low cost – rapid detection of rifampin resistant tuberculosis using bacteriophage in Kampala Uganda Ann. Clin Microbiol Antimicrob. 6:1
15. 2007 Pathogenesis and management of HIV/TB co-infection in Asia. Tuberculosis. Supp 1:S26-30
16. 2006 Comparison of intermittent ethambutol with rifampin-based regimens in HIV-infected adults with PTB, Kampala. Int J Tuberc Lung Dis. 10:39-44
17. 2006 Delayed-type hupersensitivity skin test reactivity and survival in HIV-infected patients in Uganda: Should anergy be a criterion to start antiretroviral therapy in low-income countries? Am J Trop Med Hyg. 74:39-44
18. 2006 Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts Am J Respir Crit Care Med. 173:238-45
19. 2006 Effect of tuberculosis preventive therapy on HIV disease progression and survival. HIV Clinical Trials. 7:172-83
20. 2005 Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda J Infect Dis.191: 856-65
21. 2005 Subclinical tuberculosis: a new entity? Clin Infect Dis. 41: 1069-70
22. 2005 Chronic Meningitis. In: Principles and Practice of Infectious Diseases. Churchill Livingstone, New York :pp1132-42
23. 2005 Mechanisms of apoptosis of T-cells in human tuberculosis. J Clin Immunol. 25:353-64
24. 2005 Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells. Infect Immun. 73:4505-11
25. 2004 Airborne infection with Bacillus anthracis – from mills to mail. Emerg Infect Dis. 10: 996-1002
26. 2004 A randomized, double-blind, placebo-controlled trial of the use of prednisolone as in adjunct to treatment in HIV-1- associated pleural tuberculosis. J Infect Dis. 190: 869-78
27. 2003 HIV disease progression and effects of tuberculosis preventive therapy in HIV-infected adults Ann Epidemiol. 13: 577-8
28. 2003 Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am J Epidemiol. 158;887-98
29. 2003 the HIV Network for Prevention Trials J Infect Dis. 187:887-95
30. 2003 Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis. Am J Respir Crit Care med. 168: 185-91
31. 2003 Whole blood bactericidal activity during treatment of pulmonary tuberculosis J Infect Dis. 187: 270-8
32. 2002 Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. Clin Diagn Lab Immunol. 9:818-23
33. 2002 Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity J Infect Dis. 186:1448-57
34. 2002 Gender and HIV-associated pulmonary tuberculosis: presentation and outcome at one year after beginning antituberculosis treatment in Uganda BMC Pulm Med. 2: 4
35. 2002 Whither Mycobacterium vaccae—encore. Lancet. 360:1032-3
36. 2002 Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda. J Clin Microbiol. 40:3398-405
37. 2002 Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis. Clin Diagn Lab Immunol. 9:901-7
38. 2002 First trial of the HIV-1 vaccine in Africa: Ugandan experience. Brit Med J. 324: 226-9
39. 2001 Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF- alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes – implications for pathogenesis Clin Exp Immunol 123:210-218
40. 2001 Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults. AIDS 15/16: 2137-47
41. 2001 Increased replication of HIV-1 at sites of Mycobacterium tuberculosis infection: potential mechanisms of viral activation JAIDS 28:1-8
42. 2001 Macrophage activating cytokines in human immunodeficiency virus-1 infected and uninfected subjects with pulmonary tuberculosis J. Infect Dis 183:1805-9
43. 2001 Activation of beta chemokines and CCR5 in human immundeficiency-1-infected patients with tuberculosis. J Infect Dis 183: 1801-4
44. 2001 Safety and bactericidal activity of Rifalazil in patients with pulmonary tuberculosis. Antimicrob Agents Chemother 45:1972-6
45. 2001 Quantitative bacillary response to treatment of Mycobacterium tuberculosis infected and M. africanum infected adults with pulmonary tuberculosis. Int. J Tuberc Lung Dis 5:579-82
46. 2001 Inhibition of INH-induced expression of M. tuberculosis antigen 85 in sputum: a potential surrogate marker in TB chemotherapy trials. Antimicrob Agents and Chemother 45:1302-4
47. 2001 A whole blood bactercidial assay for tuberculosis. J Infect Dis 183:1300-3
48. 2001 Impact of tuberculosis on HIV-1 activity in dually infected patients Clin Exp Immunol 123:233-38
49. 2001 Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis. J. Infect Dis 183:779-88
50. 2000 Cellular immunity to human immunodeficiency virus Type I (HIV-1) clades: Relevance to HIV-1 vaccine trials in Uganda. J. Infect Dis. 182:1350-6
51. 2000 Predicting the outcome of therapy for pulmonary tuberculosis. Am J Respir Crit Care Med 161:1076-80
52. 2000 Role of T cell subsets in the modulation of Mycobacterium avium growth within human monocytes Cell Immunol. 202:6-12
53. 2000 Expression of IL-18 by Mycobacterium avium- infected human monocytes; association with M. avium virulence. Clin Exp Immunol. 122:1-8
54. 2000 cell activation, apoptosis, and cytokine dysregulation in the (co) pathogenesis of HIV and pulmonary tuberculosis (TB). Clin Exp Immunol.122:350-357
55. 2000 Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda AIDS 14:1219-28
56. 2000 Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in health household contacts of patients with active tuberculosis and health controls from the community. J Immunol 165:1479-85
57. 2000 Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Uganda-Case Western Reserve University Research Collaboration. Int J TB & Lung Dis 4:1032-40
58. 2000 Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis. Int J TB & Lung Disease 4:528-536
59. 2000 Controlled trial of Mycobacterium vaccae immunotherapy in pulmonary tuberculosis J Infect Dis.1811304-1312
60. 2000 PPD-specific IgG1 antibody subclass up-regulate tumour necrosis factor expression in PPD-stimulated monocytes: possible link with disease pathogenesis in tuberculosis. Clin Exp Immunol.119:449-455
61. 1999 Interaction of Mycobacterium tuberculosis- induced transforming growth factor beta 1 and interleukin-10 Infec Immun 67:5730-5735
62. 1999 Measurement of Sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy. Am J Respir Crit Care Med. 160:203-210
63. 1999 Apoptosis and T Cell hyporesponsiveness in pulmonary tuberculosis. J Infect Dis. 179:945-53
64. 1999 Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 180:2069-2073
65. 1999 Drug tolerance in Mycobacterium tuberculosis Antimicrob Agents Chemother 43:2600-2605
66. 1999 The effect of bacille Calmette-Guerin vaccination at birth on tuberculin skin test reactivity in Ugandan children Int J. TB & Lung Disease. 3:891-5
67. 1998 A comparison of three composite compliance indices in a trial self-administered preventive therapy in Kampala, Uganda. J Clin Epidem. 51:597-607
68. 1998 T-cell-dependent inhibition of growth of virulent Mycobacterium tuberculosis H374v within human monocytes: Requirement for CD4+ T-cells in PPD-positive but not in PPD-negative subjects J Immunol. 160:2408-2417
69. 1998 Expression of virulence of Mycobacterium tuberculosis within human monocytes: Virulence correlates with intracellular growth and induction of TNF, but not with evasion of T-cell dependent monocyte effector functions Infect and Immun. 66:1190-1199
70. 1998 Induction of antigen 85 complex of Mycobacterium tuberculosis in sputum; a determinent of outcome in pulmonary tuberculosis treatment J Infect Dis. 178:1115-1121
71. 1998 Impact of HIV-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda; frequent presentation as typical tuberculosis. Int J TB & Lung Dis. 2:397-404
72. 1998 A Phase II/III trial of rifampin, ciprofloxacin, clofazimine, ethambutol, with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS. 12:2439-46
73. 1998 Pentoxifylline in HIV & TB: Safety at 4 years. (Letter). J Infect Dis. 178:1861
74. 1998 Instability of tuberculin and candida skin test reactivity in HIV-infected Ugandans. Am J Respir Crit Care Med. 158:1790-1796
75. 1998 A prospective study of immunity-required blood stream infections among febrile adults admitted to Mulago Hospital in Kampala Uganda. J AIDS and Human Retrovir. 19:484-489
76. 1998 Role of CR4 in Mycobacterium tuberculosis-human macrophages binding and signal transduction in the absence of serum. Infect Immun. 66:4541-4544
77. 1997 Immunologic screening of a genomic M. bovis BCG library expressed in M. smegmatis and identification of the M. bovis BCG ClpB analog. Tuber Lung Dis. 78:133-141
78. 1997 Immune response profile in patients with active tuberculosis in a BCG-vaccinated area. Southeast Ansian J Trop Med. Public Health. 28:764-773
79. 1997 Activity of new quinolones against intracellular Mycobacterium avium in human monocytes. J Antimicrobial Chemother, 40:841-845
80. 1997 Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in HIV-infected adults. Int J TB Lung Dis. 1:441-445
81. 1997 HIV-1 risk and vaccine acceptability in the Ugandan military. J AIDS. 15:375-380
82. 1997 Altered IL-1 expression and compartmentalization in monocytes from patients with AIDS stimulated with Mycobacterium avium complex. J Clin Immunol, 17:387-395
83. 1997 Risk factors for relapse in HIV-1 infected adults with pulmonary tuberculosis. Int J TB & Lung Dis. 1:446-53
84. 1997 A trial of three regimens to prevent tuberculosis in HIV-infected Ugandan adults infected with the human immunodeficiency virus. Uganda – Case Western Reserve University Research Collaboration. N Engl J Med. 337:801-88
85. 1997 Induction of nuclear factor (NF) and its inhibitor, I/MAD-3, in monocytes by M. tuberculosis and during tuberculosis J. Immunol. 159:4109-16
86. 1997 Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis. AIDS. 11:455-60
87. 1997 Restoration of T-cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor-beta Proc Natl Acad Sci, USA. 94:3926-3931
88. 1997 Two-step tuberculin skin testing in HIV-infected persons in Uganda. Am J Respir Crit Care Med. 155:81-86
89. 1996 Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection Clin Exp Immunol. 103:30-34
90. 1996 Evidence against a role for interleukin-10 in regulation of growth of Mycobacterium avium within human monocytes. J Infect Dis. 173:410-417
91. 1996 Immune activation, allergic drug toxicity and mortality in HIV positive tuberculosis. Tubercle. 77:516-523
92. 1996 Induction of prostaglandin E2 by human monocytes infected with Mycobacterium avium complex - Modulation of cytokine expression. J Infect Dis. 174:806-811
93. 1996 Induction of monocyte expression of tumor necrosis factor alpha by the 30kDa alpha antigen of Mycobacterium tuberculosis and synergism with fibronectin. J Clin Invest. 98:1261-1268
94. 1996 Pentoxifylline in HIV-1 seropositive tuberculosis: a randomized controlled trial J Infect Dis. 174:727-733
95. 1996 Predictors of survival in HIV-infected patients with pulmonary tuberculosis. Makerere University-Case Western Reserve University Research Collaboration. Am J Respir Crit Care Med. 153:1977-1981
96. 1996 Delayed tuberculin reactivity in persons of Indochinese origin: Implications for preventive therapy. Ann Intern Med. 124:779-784
97. 1996 An inexpensive method for packaging antituberculosis treatment drugs Lancet. 347:834
98. 1996 Comparison of the activity of fluoroquinolones against Mycobacterium avium in cell-free systems and an in vitro human monocyte infection model. J Antimicrob Chemother. 37:491-500
99. 1996 Pulmonary tuberculosis in a BCG vaccinated area: relationship of disease severity with immunological and haematological parameters and drug resistance patterns. Southeast Asian J of Trop Med and Public Health. 27:257-262
100. 1996 Cross-modulation by transforming growth factor in human tuberculosis; suppression of antigen-driven blastogenesis and interferon production. Proc. Natl Acad Sci (USA). 93:3193-3198
101. 1996 Selective induction of transforming growth factor in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect Immun. 64:399-405
102. 1995 Simultaneous comparison of two commercial tuberculin skin testing reagents in a high prevalence area. J Infect Dis. 171:1066-1067
103. 1995 Accelerated clinical course of human immunodeficiency virus infection following active tuberculosis. Am J Respir Crit Care Med. 151:129-35
104. 1995 Enhanced expression of transforming growth factor-beta (TGF) by blood monocytes from patients with active tuberculosis and presence of TGF in tuberculosis granulomatous lung lesions. J Immunol. 154: 465-73
105. 1995 Selective increases in antibody isotypes and IgG subclass responses to secreted antigens in tuberculosis patients and household contacts. Clin Diagn Lab Immunol. 2:726-32
106. 1995 Regulation of tumor necrosis factor-alpha production by monocytes stimulated by the 30 kDa antigen of Mycobacterium tuberculosis. Infect Immunol. 63:3206-3208
107. 1995 Mapping of T-cell epitopes of the 30kD alpha antigen of Mycobacterium bovis BCG in PPD-positive individuals J Immunol. 154:4665-4674
108. 1995 Induction of transforming growth factor-beta (TGF-beta) by purified protein derivative (PPD) of Mycobacterium tuberculosis. Infect Immun. 63:224-228
109. 1994 Modulation of the effector function of human monocytes for Mycobacterium avium by human immunodeficiency virus-1 envelope glycoprotein (GP120). J. Clin. Invest. 93:885-91
110. 1994 A randomized trial of thiacetazone- and rifampin-containing therapies for pulmonary tuberculosis in HIV-infected Ugandans. Lancet. 344:1323-28
111. 1994 In vitro anti-Mycobacterium avium activities of quinolones. Predicted active structures and mechanistic considerations. Antimicrob Agents Chemother. 38:1794-1802
112. 1994 Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor beta. J Infect Dis. 170:1229-1237
113. 1994 Mycobacterium avium: pathogenicity in HIV1 infection. Res. Microbiol. 145:230-236
114. 1994 Complement-mediated uptake and tumor necrosis factor - mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J. Immunol. 152:743-753
115. 1993 Transient normalization of lymphocyte blastogenic and specific antibody responses following boosting of healthy elderly subjects with tetanus toxoid. J. Gerontol. Med Sci. 48:M19-25
116. 1993 Screening of a cosmid library of Mycobacterium bovis-BCG in Mycobacterium smegmatis for novel T-cell stimulatory antigens Res. Microbiol. 144:349-362
117. 1993 Anti-Mycobacterium avium activity of quinolones: Structure-activity relationship studies Antimicrob. Agents Chemother. 37:1807-1815
118. 1993 Anti- Mycobacterium avium activity of quinolones: In vitro activities. Antimicrob. Agents Chemother. 37:1799-1806
119. 1993 Colonial morphotype as a determinant of cytokine expression by human monocytes infected with Mycobacterium avium. J Immunol. 150:2945-2954
120. 1993 Inhibition of growth of Mycobacterium avium in murine and human mononuclear phagocytes by migration inhibitory factor. Infect Immun. 61:338-342
121. 1993 Synergy of Mycobacterium tuberculosis and HIV-1: Enhanced cytokine expression and elevated 2 microglobulin in HIV-positive tuberculosis. J. Infect. Dis. 167:43-48
122. 1993 Accessory function and properties of monocytes from healthy elderly humans for T-lymphocyte responses to mitogen and antigen. Gerontology. 39:93-108
123. 1992 Duration of fever during treatment of infective endocarditis. Medicine 71:52-57
124. 1992 The role of the mononuclear phagocyte as an antigen-presenting cell for human gamma-delta T-cells activated by live Mycobacterium tuberculosis. Infect Immun 60:3480-8
125. 1992 UV-irradiated monocytes efficiently inhibit the intracellular replication of Mycobacterium avium-intracellulare. J Clin Invest 89:1274-1287
126. 1992 Risk factors for HIV infection in Homosexual Men: The Cleveland Men's Study of risks in a low prevalence area and a review of the literature. Cleveland Clinic J Med. 59:573-80
127. 1992 Absence of Mycobacterium avium complex disease in patients with AIDS in Uganda. J Acquired Immune Def Syn 5:477-478
128. 1991 Selective expansion of human gamma-delta T-cells by monocytes infected with live Mycobacterium tuberculosis. J. Clin. Invest. 87:729-733
129. 1991 Preservation of monocyte effector functions against Mycobacterium avium-M. intracellulare in patients with AIDS Infect. Immun. 59:3639-3645
130. 1991 Nineteen year follow-up of tuberculin reactors: assessment of skin test reactivity and in vitro lymphocyte response. Chest 99:1172-1176
131. 1991 The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda. Am. Rev. Respir. Dis. 143:185-187
132. 1991 Release of a suppressor cell-inducing factor by monocytes from patients with pulmonary tuberculosis. Immunology 72:194-198
133. 1991 Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes. J. Immunol. 146:3165-3170
134. 1991 Requirement for cell-to-cell contact for the immunosuppressive activity of human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 4:287-294
135. 1991 Direct mitogenic properties of interleukin-1. J. Lab. Clin. Med. 117:234-240
136. 1991 EBV-transformed B-lymphoblastoid cell lines are resistant to the adverse effects of UV-radiation on their accessory function. Eur. J. Immunol. 21:291-297
137. 1991 Human immune response to Mycobacterium tuberculosis antigens. Infect. Immun. 59:665-670
138. 1990 UVB radiation and human monocyte accessory function: differential effects on pre-mitotic events in T-cell activation. J. Invest. Dermatol. 94:204-209
139. 1990 Measurement and partial characterization of an interleukin-2 inhibitor (IL-2-IN) in human urine. J. Biol. Regul. Homeost. Agents 4:73-80
140. 1990 Strain and donor-related differences in the interaction of Mycobacterium-avium with human monocytes and its modulation by interferon-gamma. J. Infect. Dis. 162:932-938
141. 1990 Absence of bacteremia with Mycobacterium avium-intracellulare in Ugandan patients with AIDS. J. Infect. Dis. 162:208-210
142. 1990 Induction of interleukin-1 and tumor necrosis factor by mycobacterial proteins: the monocyte Western blot. Proc. Natl. Acad. Sci. 87:3348-3352
143. 1990 Expression of functional IL-2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis. J. Clin. Invest. 85:1777-1784
144. 1990 The cell membrane is a major locus for ultraviolet-B-induced alterations in accessory cells. J. Clin. Invest.85:1529-1536
145. 1990 Regulation of antigen-induced blastogenesis and interleukin-2 expression by adherent mononuclear cells in humans infected with Schistosoma mansoni. J. Infect. Dis. 161:1284-1289
146. 1990 Dissociation of immunoregulatory function of blood monocytes from maturational state and expression of interleukin-1 in humans chronically infected with Schistosoma mansoni. Am. J. Trop. Med. Hyg. 42:234-242
147. 1989 Urinary interleukins in patients receiving intravesical Bacillus Calmette-Guerin therapy for superficial bladder cancer. Cancer 64:1447-1454
148. 1989 Identification of antigens of Mycobacterium tuberculosis using human monoclonal antibodies. J. Clin. Invest. 84:214-219
149. 1989 Dyscoordinate expression of tumor necrosis factor-alpha and human blood monocytes and alveolar macrophages. Am. Rev. Respir. Dis. 139:1010-1016
150. 1989 Suppression of PPD-induced interleukin-2 production by interaction of Leu-11 (CD16) positive lymphocytes and adherent mononuclear cells in tuberculosis. J. Infect. Dis. 159:352-356
151. 1989 Regulation of human T-cell production of interleukin-2 by Leu-11 (CD16) positive large granular lymphocytes Cell. Immunol. 118:413-424
152. 1989 Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage activating factor activity of gamma interferon Infect. Immun. 57:239-244
153. 1988 Mediation of augmented monocyte adhesiveness by thromboxane. Inflammation 12:1-9
154. 1988 To biopsy or not to biopsy in suspected herpes simplex encephalitis: A quantitative analysis. Med Decis Making 8:95-101
155. 1988 Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect. Immun. 56:3313-3315
156. 1988 Immunogenetic analysis of human tuberculosis. J. Infect. Dis. 158:1302-1308
157. 1988 Cardiomyopathy associated with the acquired immune deficiency sydrome. Journal of Acquired Immune Deficiency Syndromes 1:105-110
158. 1988 Defective accessory function of monocytes in human immunodeficiency virus-related disease syndromes. J. Lab. Clin. Med. 112:174-81
159. 1988 Cell-mediated immune responses in human infection with Onchocerca volvulus. J. Immunol. 140:1999-2007
160. 1987 Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL-2 production and IL-2 receptor expression in T-lymphocytes J. Immunol. 138:197-203
161. 1987 Deleterious effects of ultraviolet-B radiation on accessory function of human blood adherent mononuclear cells Clin. Exp. Immunol. 70:116-126
162. 1987 Lymphocytes of persons with the acquired immunodeficiency syndrome and related conditions express reactivity with the monoclonal antibody 4D12 reflective of in vivo lymphocyte activation Human Immunol 20:279-291
163. 1987 Failure of immunosuppressive mechanisms in human Schistosoma mansoni infection with hepatosplenomegaly J. Clin. Micro. 25:768-773
164. 1987 Antigen responsiveness during tuberculosis: regulatory interaction of T-cell subpopulations and adherent cells J. Lab Clin. Med. 110:31-40
165. 1987 Spectrum of immunoregulatory functions and properties of human alveolar macrophages Am. Rev. Respir. Dis. 136:258-265
166. 1987 Augmentation of skin test reactivity and lymphocyte blastogenesis in patients with the acquired immunodeficiency syndrome treated with transfer factor. JAMA 257:651-5
167. 1987 Diagnosis of nosocomial pneumonia in intubated intensive care unit patients Am. Rev. Resp. Dis. 135:426-32
168. 1986 Concurrent enhancement of monocyte immunoregulatory properties and effector function by recombinant interferon-gamma. Cell. Immunol. 100:34-46
169. 1986 Preliminary characterization of accessory cells in the nonadherent fraction of human blood mononuclear cells. Cell. Immunol. 103:339-51
170. 1986 Differential contribution of chemotaxis and opsonins to neutrophil-mediated killing of S. mansoni larvae Infect. Immun. 52:748-755
171. 1986 Staphylococcal protein A-primed leukocytes enhance stimulation of the autologous mixed lymphocyte reaction Am. J. Med. Sci. 29:255-263
172. 1986 Defective interleukin-2 production and responsiveness in human pulmonary tuberculosis. J. Exp. Med. 163:1162-1172
173. 1986 Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. Am. Rev. Respir. Dis. 133:73-7
174. 1986 Inhibition of human lymphocyte proliferation by ultraviolet radiation: effects of ultraviolet B (290-320 nM) on T-lymphocytes, monocyte accessory function and induction of suppressor mechanisms J. Lab. Clin. Med. 107:66-72
175. 1986 Spontaneous production of a suppressor factor by the human macrophage-like cell line U937. I. Suppression of interleukin-1, interleukin-2 and mitogen-induced blastogenesis in mouse thymocytes. J. Immunol. 136:181-85
176. 1986 Direct stimulation of monocyte release of interleukin-1 by mycobacterial protein antigens. J. Immunol. 136:193-96
177. 1985 Increased blastogenic responses to worm antigen and loss of adherent suppressor cell activity after treatment for human infection with Schistosoma mansoni. J. Infect. Dis. 151:320-324
178. 1985 Stress as a precipitating factor in subjects with recurrent herpes labialis. J. Fam. Prac. 20:359-366
179. 1985 Lack of correlation between promiscuity and seropositivity to HTLV-III from a low incidence area for AIDS N. Engl. J. Med. 312:1256-1257
180. 1985 Immunoregulatory adherent cells in human tuberculosis: Radiation-sensitive antigen-specific suppression by monocytes J. Infect. Dis. 152:171-176
181. 1985 Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs. J. Antimicrob. Agents Chemother. 27:285-290
182. 1984 Augmentation of natural killer cell activity by lipopolysaccharide through separable effects on the binding of nonadherent lymphocytes to tumor targets and tumor killing. Cancer Res. 44:1044-1047
183. 1984 Modulation of macrophage activation and resistance by suppressor T-lymphocytes in chronic murine Schistosoma mansoni infection. J. Immunol. 133:2720-2724
184. 1984 Association of altered dynamics of monocyte surface expression of human leukocyte antigen-DR with immunosuppression in tuberculosis J. Infect. Dis. 149:3l-37
185. 1983 Recruitment of OKM1 staining lymphocytes with selective binding to K562 tumor targets by interferon. Clin. Exp. Immunol. 52:185-190
186. 1983 Divergent T-gamma cell functions in antigen-blastogenesis: facilitory interactions with T non-gamma cells and participation in monocyte- and prostaglandin-mediated suppression. J. Lab. Clin. Med. 102:751-761
187. 1983 Radioresistance of culture-induced augmented natural killer activity. Human Immunol. 7:151-162
188. 1983 Non-specific suppression of antigen-induced lymphocyte blastogenesis in human Onchocerca volvulus infection in man Clin. Exp. Immunol. 52:259-265
189. 1983 Two distinctive patterns of monocyte immunoregulatory and effector functions in heavy human infections with Schistosoma mansoni. J. Immunol. 131:954-958
190. 1983 Ultraviolet radiation inhibits human natural killer activity and lymphocyte proliferation. J. Immunol. 130:2484-2487
191. 1982 A possible role for cold insoluble globulin in chemotactic factor mediated polymorphonuclear leukocyte adherence to plastic. Biochem. Biophys. Acta. Res. Commun. 106:471-478
192. 1982 Destruction of the multicellular parasite Schistosoma mansoni by T-lymphocytes. J. Clin. Invest. 70:369-378
193. 1981 Augmentation of selective monocyte functions in tuberculosis. J. Infect. Dis. 144:391-398
194. 1981 Augmented neutrophil adherence in active and remote tuberculosis. Am. Rev. Respir. Dis. 124:643-645
195. 1981 Defective suppressor cell generation in juvenile onset diabetes. J. Immunol. 127:2051-2055
196. 1981 Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan: monocyte dependence and indomethacin reversibility. J. Clin. Invest. 68:153-162
197. 1981 Spontaneous cytotoxicity of human peripheral blood mononuclear cells for the lymphoblastoid cell line CCRF-CEM. Augmentation by bacterial lipopolysaccharide. Clin. Exp. Immunol. 46:640-648
198. 1981 Amphotericin B-induced resistance to Schistosoma mansoni. J. Immunol. 126:1667-1670
199. 1981 Generation of suppressor T-lymphocytes and monocytes by amphotericin B. J. Immunol. 127:135-139
200. 1981 Generation of a soluble immune response suppressor factor (IRSF) by unstimulated leucocytes of healthy subjects. Clin. Exp. Immunol. 45:191-200
201. 1981 Monocyte-mediated killing of schistosomula of Schistosoma mansoni: alterations in human schistosomiasis mansoni and tuberculosis J. Immunol. 127:1538-1542
202. 1981 Dichotomies in the reactivity to worm antigen in human Schistosomiasis mansoni. J. Immunol. 126:309-312
203. 1980 Role of arginase in killing of schistosomula of Schistosoma mansoni. J. Exp. Med. 151:1557-1562
204. 1980 Interrelationships of immunoregulatory cells and serum factors in sarcoidosis. J. Immunol. 125:1071-1077
205. 1980 Suppressor splenic T lymphocytes in human hepatosplenic Schistosomiasis mansoni. J. Immunol. 125:308-312
206. 1980 Thromboxane A2 mediates augmented polymorphonuclear leukocyte adhesiveness. J. Clin. Invest. 66:406-414
207. 1980 Comparative stimulation of granulocyte adherence and chemotaxis by bacterial products Infect. Immun. 27:519-524
208. 1980 Purification of Giardia muris trophozoites by using nylon fiber columns. Am. J. Trop. Med. Hyg. 29:12-15
209. 1979 Immunosuppression by mycobacterial arabinomannan. Clin. Exp. Immunol. 35:250-257
210. 1979 Immunobiology and species distribution of Mycobacterium tuberculosis Antigen 5. Infect. Immun. 24:77-82
211. 1979 Suppression of antigen and mitogen-induced human T lymphocyte DNA synthesis by bacterial lipopolysaccharide: mediation by monocyte activation and production of prostaglandins. J. Immunol. 123:2689- 2695
212. 1979 Killing of schistosomula of Schistosoma mansoni by normal human monocytes. J. Immunol. 123:949-951
213. 1979 Salicylate blockade of granulocyte adherence and the inflammatory response to experimental peritonitis Blood 53:1018-1022
214. 1979 Tuberculin response of lymphocytes from human skin test nonreactors: evidence for in vitro primary sensitization of T-lymphocytes. Cell. Immunol. 45:213-220
215. 1979 Concurrent responses of peripheral blood and splenic mononuclear cells to antigenic and mitogenic stimulation in human hepatosplenic schistosomiasis J. Infect. Dis. 140:162-168
216. 1978 Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside Lancet II:604-606
217. 1978 Suppressor adherent cells in human tuberculosis J. Immunol. 121:2573-2578
218. 1978 Pleural fluid and peripheral blood lymphocyte function in tuberculosis Ann. Intern. Med. 89:932-933
219. 1978 Double blind comparison of cefamandole and penicillin in pneumococcal pneumonia. Antimicrob. Agents Chemother. 14:13-23
220. 1977 Antigen handling by guinea pig macrophages: further evidence for the sequestration of antigen relevant for activation of primed T-lymphocytes. J. Immunol. 118:2053-2057
221. 1977 Induction of guinea pig antibody responses in vitro. J. Immunol. 118:2034-2039
222. 1976 Phytohemagglutinin induced proliferation of guinea pig thymus-derived lymphocytes. II. Accessory cell function. J. Immunol. 116:876-880
223. 1976 Phytohemagglutinin induced proliferation of guinea pig thymus-derived lymphocytes. I.  Accessory cell dependence. J. Immunol. 116:868-875
224. 1975 Quantitative and immunologic aspects of the handling of 2,4 dinitrophenyl guinea pig albumin by macrophages J. Immunol. 114:1563-1569
225. 1966 interactions in the silicon-nitrogen bond. An experimental test. J. Am Chem. Soc. 88:622
226. 1966 Tuberculosis and Atypical Mycobacterial Infections. In TROPICAL INFECTIOUS DISEASES: PRINCIPLES, PATHOGENS, AND PRACTICE, In print
227. 1966 Group IV - Nitrogen stretching frequencies. An unequivocal assignment Inorganic and Nucl. Chem. Letters 1:109-112

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.